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Autologous epidermal cell cultures (CEA) represent a possibility to treat extensive burn lesions, since they allow a signiﬁcative
surface expansion which cannot be achieved with other surgical techniques based on autologous grafting. Moreover currently
availableCEApreparationsarediﬃculttohandleandtheirtakerateisunpredictable.Thisstudyaimedatproducingandevaluating
anewcutaneousbiosubstitutemadeupofalloplasticacellularglycerolizeddermis(AAGD)andCEAtoovercomethesediﬃculties.
A procedure that maintained an intact basement membrane was developed, so as to promote adhesion and growth of CEA on
AAGD. Keratinocytes were seeded onto AAGD and cultured up to 21 days. Viability tests and immunohistochemical analysis with
speciﬁc markers were carried out at 7, 14, and 21 days, to evaluate keratinocyte adhesion, growth, and maturation. Our results
support the hypothesis that this newly formed skin substitute could allow its permanent engraftment in clinical application.
1.Introduction
The burn patient is prone to a complex, articulated, and
polymorphous clinical picture, based on a systemic inﬂam-
matory response, aﬀecting multiorgan function, with a high
mortality rate. As extensive burns generate large areas of
necrotic skin, the therapeutic priority is the removal of the
necrotic tissue, so as to limit the inﬂammatory response.
Although autologous skin grafting is the gold standard for
deﬁnitive wound coverage, it is diﬃcult to ﬁnd suitable
donor areas in a patient with extensive burns [1, 2]. Dermal
skin substitutes may be used to handle the problem of donor
site shortage when dealing with major skin loss. Indeed,
recent developments in the multidisciplinary ﬁeld of tissue
engineeringhaveyieldedmanynoveltissuereplacementsand
implementation strategies. Scientiﬁc advances in biomate-
rials, stem cell isolation, growth and diﬀerentiation factors,
and biomimetic environments have created unique opportu-
nitiestoproducetissuesinthelaboratory.However,although
there have been enormous advances in the development of
skin substitutes over the last 3 decades, there are still major
obstacles to be overcome in the quest for an optimal skin
substitute.
Successful treatment in burn care with dermal skin
substitutes requires low antigenicity, the capacity for rapid
vascularization and a stable dermal template. Even if, to date,
the best cutaneous substitute remains alloplastic skin, it does
not ensure a permanent reconstruction and tends towards
rejection. For some decades this problem was solved by
surgical techniques, based on a combination of tissue and/or
cell auto/allografts [3–7]. Human alloplastic grafts were used
to support cultivated autologous keratinocytes (CEA) in a
clinical setting, oﬀering a permanent wound coverage with
the Cuono technique. However it has the drawback that the
CEA take is not always reproducible, making it somewhat
unpredictable [8–10].
The combination of technical diﬃculties including high
costs, unpredictable graft take, and prolonged instability
of the grafts has led researchers to carry out research in
an eﬀort to ﬁnd more resilient substitutes. To this aim,
donor skin allografts preserved in 85% glycerol are often
used as a temporary coverage for large burn wounds, as
glycerol does not aﬀect the structural integrity of the skin
[11]. Indeed, the glycerol-preserved skin allograft, although
devitalised, does retain its morphological structure and,
therefore, can be used as a temporary skin substitute, or2 Journal of Biomedicine and Biotechnology
grafted as a dermal template. Glycerol-preserved allografts,
that have advantageous biomanual properties, are being
investigated as scaﬀolds for tissue engineering applications.
The aim of the research reported herein was an in vitro
construction of a skin substitute made up of an alloplastic
acellularglycerolizeddermis(AAGD)scaﬀolddirectlyseeded
with low-density keratinocytes.
2.MaterialsandMethods
The study was carried out according to a protocol approved
by the CTO/San Giovanni Battista Hospital Institutional
Ethical Board (Turin, Italy prot. 0046054) and written
informed consent was obtained from all patients included.
2.1. The Scaﬀold Preparation and De-Epithelialization.
Donor skin grafts (about 20cm2), preserved at 85% glycerol
in the Turin Skin Bank and unﬁt for transplantation,
were used as the skin substitute scaﬀold. The glycerol was
removedfromthegraftsbysequentialwashinginsterile0.9%
saline solution at +37◦C. The grafts were then incubated
overnight at +33◦C under continuous shaking in RPMI
1640 (GibcoLife Technologies, Grand Island, NY, USA) and
supplemented with 1% human albumin (Farma Biagini,
Italy), Vancomycin 100μg/mL (Vanco, Pulitzer Italiana srl;
Roma, Italy), Imipenem 100μg/mL (Tienam, Merck, Sharp
and Dohme, Italy), sulfametoxazole-trimethoprim 50μg/mL
(Bactrim, Roche, Milan, Italy) and Fluconazole 50μg/mL
(Diﬂucan, Pﬁzer Italiana, Italy). The following day, the
epidermal layer was removed by three diﬀerent techniques:
one using dispase II (3h at +37◦Ci n5 %C O 2), another
trypsin (3h at +37◦Ci n5 %C O 2) and the third without
the use of any enzyme, with only manual removal. The
manual removal involved massaging the graft by hand, for
an average of one minute for an allograft of about 20cm2.
This procedure was followed by manual stripping of the
epidermal layer, which detached very easily. This detachment
was facilitated by its overnight incubation and continuous
shaking, as reported above. The whole procedure was
simple and reproducible by any of the laboratory personnel
(Figure 1).
2.2. Keratinocyte Cultures. Human split-thickness skin grafts
(0.4mm thick) were obtained from healthy individuals.
Serial enzymatic cell separation was used to obtain cell
suspensions from these samples using 2mg/mL dispase II
(Roche Manheim, Germany) and trypsin 0.05% (Invitro-
gen Life Technologies, USA). The cells, plated at 1.6 ×
104 cells/cm2 density, were grown on a irradiated 3T3-
J2 layer, as described by Rheinwald and Green [12], in
Dulbecco’s Modiﬁed Eagle Medium (DMEM, Gibco, UK)
and 10% fetal bovine serum (FBS, New Zealand origin)
supplemented with 5μg/mL insulin (Sigma-Aldrich, USA),
0.4μg/mL hydrocortisone (Sigma-Aldrich, USA), 10
−10 M
cholera toxin (Sigma-Aldrich, USA), 2×10
−10 M triiodothy-
ronin(Sigma-Aldrich,USA),5μg/mLapo-transferrin(Invit-
rogen Life Technologies, USA), 2mM glutamine (Sigma-
Aldrich,USA),and50UI/mLpenicillin-streptomycinantibi-
oticsolution.Theﬂaskswereincubatedat+37◦Cin5%CO 2.
At the ﬁrst medium change (5 days after the initial plating),
the medium was further supplemented with 10ng/mL
epidermal growth factor (Sigma-Aldrich, USA) and changed
every 48−72 hours.
2.3. Preparation of Keratinocyte Suspension. Primary cul-
tures of human keratinocytes were grown to approximately
80% conﬂuence after about fourteen days. The cells were
enzymatically separated by digestion with 0.05% trypsin
(Invitrogen Life Technologies, USA). Residual 3T3-J2 were
removed before harvesting by washing with 0.05% trypsin.
The recovered keratinocytes were rewashed and resuspended
in culture medium, at a density of 4 × 105cells/mL. A
syringe was ﬁtted with a spray cap to nebulize 5mL of
these suspensions onto a de-epithelialized dermis (20cm2),
which were then incubated at +37◦Ci n5 % C O 2,f o r
21 days.
Serial enzymatic cell separation was used to obtain
keratinocyte suspensions from the skin biopsy as reported
above. They then were sprayed at 1.5×105cells/cm2 onto the
scaﬀoldand theculturemedium waschangedevery2-3days.
The keratinocytes were nebulized onto the scaﬀold without a
murine 3T3-J2 ﬁbroblast feeder layer.
2.4. Proliferation Assay. Enzyme activity was assessed to
deﬁne the skin substitute viability with an MTT test (Roche
GmbH, Mannheim, Germany) at 7, 14, and 21 days after
spraying, as described by Alotto et al. [13]. Spectrophotome-
ter readings were performed at 570nm, with an Eppendorf
BioPhotometer.
2.5. Tissue Specimens and Staining Procedure. Two six-
millimetre punch biopsies were made at 7, 14, and 21 days
after cell nebulization: one was snap frozen in isopentane
and stored at −70◦C, the other was included in paraﬃn
for histological analysis. Frozen sections (7μm) were air-
dried, acetone ﬁxed and incubated with primary mouse
monoclonal antibodies (MoAb), followed by avidin-biotin,
as previously described [14]. Staining was developed with
3-amino-9-ethyl carbazole as a chromogen and the sections
were then counterstained with Mayer’s hematoxylin solution
and mounted with glycerol gelatine. The second MoAb was
detected by the avidin-biotin-horseradish peroxidase system
(DAKO, Milan, Italy). The mouse antihuman MoAb used
in this paper included: CD3 (clone SK7; dilution 1:10;
Becton Dickinson, USA), CD68 (clone EBM11; dilution
1:100; Dako, USA), CD83 (clone HB15a; dilution 1:20;
Immunotech, France), cytokeratin (clone AE1/AE3; dilution
1:50; Dako, USA), cytokeratin 14 (clone LL002; dilution
1:10; Vector Laboratories, USA), cytokeratin 16 (clone
LL025;dilution1:20;VectorLaboratories,USA),E-cadherin
(clone NCH-38; dilution 1:50 DakoCytomation, USA),
laminin (clone 4C7; dilution 1:100; DakoCytomation, Den-
mark), laminin V (clone P3H9-2; dilution 1:100; Chemicon
International, USA), collagen IV (clone CIV 22; dilution
1:100; DakoCytomation, Denmark), collagen VII (dilution
1:100; Millipore, USA). Histological analysis was performed
to conﬁrm specimen adequacy.Journal of Biomedicine and Biotechnology 3
De
E
(a)
De
E
(b)
Figure 1:Themanualremovalinvolvedmassagingthegraftbyhand(a)followedbymanualstrippingoftheepidermallayer,whichdetached
very easily (b); E: epidermis, De: dermis.
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Figure 2: The dermis basement membrane obtained by the three diﬀerent techniques stained with Collagen IV MoAb. (a) Dispase II, (b)
Trypsin, (c) the manual method. Only the manual method left an integral structure. Arrows indicate the absence of basement membrane.
Original magniﬁcation: 10x. AAGD: alloplastic acellular glycerolized dermis; BM: basement membrane.
2.6.QuantitativeAnalysisofDermisInﬁltratingCells. Stained
cells were counted in three sequential sections for each spec-
imen, with separate consideration given to the subpapillary
and reticular dermis. At least 6 series of three sequential
sections were analysed for each biopsy and 8 high-power
random ﬁelds analysed and counted for each section. The
T cell subpopulation was evaluated by staining inﬁltrating
cells with Moab antiCD3 molecule, whilst macrophages with
antiCD68 MoAb and DDC population were detected with
antiCD83 MoAb.
3. Results
3.1. The Scaﬀold Preparation. The glycerolized allografts
were de-epithelialized with three diﬀerent methods and used
as a scaﬀold for keratinocyte growth and diﬀerentiation. The
ﬁrst method used dispase II, which cleaves the anchoring
system between the dermis and epidermis. The second
used trypsin, which breaks-down the single cells, producing
a cellular suspension. The third was a manual method
without the use of any enzyme. Speciﬁc markers and
immunohistochemistry assessed the basement membrane
of all the three types of dermis. The scaﬀold was then
nebulized with keratinocytes and cell adhesion analysed by
immunohistochemistry and histology.
3.1.1. The Basement Membrane. The presence of a basement
membrane was assessed by immunohistochemical analysis
on the three diﬀerent preparations of AAGD scaﬀolds. Spe-
ciﬁcbasementmembraneglycoproteinmonoclonalantibod-
ies were directed against pan-laminin, laminin 5, collagen
IV and VII were evaluated. Immunohistochemistry demon-
strated that dispase II had completely removed the basement
membrane in all sections analysed (Figure 2(a)). Trypsin had
left only a few, incomplete basement membrane in limited
areas of the dermis (Figure 2(b)). Conversely, the manual4 Journal of Biomedicine and Biotechnology
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Figure 3: Histomorphological analysis of the dermis obtained by the three diﬀerent techniques nebulized with keratinocytes. The sample
refers to the 14th day ((a), (b), and (c)) and to the 21st day ((d), (e), and (f)), (a) and (d) Dispase II, (b) and (e) Trypsin, (c) and (f): the
manual method. Nebulized cell adherence was observed only in the one prepared manually. Original magniﬁcation: 10x ((a), (d), (e) and
(f)) 5x ((b) and (c)). AAGD: alloplastic acellular glycerolized dermis; NFE: newly formed epithelium.
method had left the membrane intact throughout the dermis
proﬁle, as shown in Figure 2(c). Pan-laminin and laminin
5MoAb were positive in the whole basement membrane
in all these specimens, with a strong collagen IV and VII
positivity (data not shown).
3.1.2. Analysis of Keratinocyte Adhesion. The three types of
dermis were nebulized with uncultured, or primary culture
keratinocytes and analysed by histology at 7, 14, 21 days
after cell seeding. After dispase II treatment, in the absence
of basal membrane, the dermal sections had only a few cells
attachedtothealloplasticscaﬀoldat7days(datanotshown).
Moreover, cell detachment was observed at two weeks,
indicating poor cell adhesion to the scaﬀold (Figure 3(a))
i n d e e dt h e r ew e r en oc e l l sa t2 1d a y s( Figure 3(d)). Those
obtained with the trypsin method showed the presence of
cellular foci on the dermis at 7 days, whilst there was a
noncontinuouscellularmonolayerat14(Figure 3(b))and21
days (Figure 3(e)).
The biosubstitute sections, obtained with the third man-
ual method, showed one or two continuous cell layers at 7
days,at14therewasapluristratiﬁedepithelium(Figure 3(c))
and a diﬀerentiated epithelium with corneous layer at 21
days(Figure 3(f)).Therewasnodetachmentofkeratinocytes
from the basal membrane.
3.2. The Scaﬀold Analysis
3.2.1. AAGD Immunogenicity. T h ep r e s e n c eo fi m m u n o -
competent cells in the AAGD tissue was determined by
immunohistochemistry on the tissue sections. There was
no staining with speciﬁc antibodies directed against T
lymphocytes, macrophages, or dermal dendritic cells at
5 days of culture (data not shown). Histomorphologi-
cal analysis showed the presence of nonviable inﬁltrating
cells in the skin section at day 0 (Figure 4(a)), the cells
decreased at 2 days (Figure 4(b)) and were negative as
from 7 days, as demonstrated in Figures 4(c) and 4(d)Journal of Biomedicine and Biotechnology 5
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Figure 4: Histomorphological analysis performed on the de-epithelialized dermis to verify the integrity of the tissue architecture and
determine the cell presence over time. Sections were stained with Mayer’s hematoxylin solution. (a) at day 0, after the glycerol removal
and before the de-epithelialization: arrows indicate the presence of inﬁltrating cells; (b) at 2 days, (c) at 7 days, (d) at 14 days. The number
of ghost cells decrease constantly over time and are no longer present as from 7 days. Original magniﬁcation: 10x. E: epidermis, De: dermis,
AAGD: alloplastic acellular glycerolized dermis.
were there was no staining of the nuclei at 7 or 14
days.
3.2.2. Assessment of the AAGD Viability. An MTT quantita-
tive analysis was also carried out on the scaﬀold to determine
the AAGD viability. The scaﬀold viability was compared to
the fresh skin sample. The terms “fresh sample” indicate a
specimen analysed immediately after harvesting and used as
apositivecontroltodescribethe100%viabilityactivityinthe
MTT assay. The results conﬁrm the immunohistochemistry
data (Figure 5).
3.3. The Biosubstitute Analysis. As only the manual method
left the basement membrane intact, it was selected and used
for the preparation of the biosubstitute scaﬀold, that is, the
object of this work (AAGD). Keratinocytes obtained, either
directly from the biopsy (uncultured cells), or after in vitro
primary culture, were seeded by means of nebulization onto
the scaﬀold in the absence of a murine 3T3-J2 ﬁbroblasts
feederlayer.Qualitycontrolonthekeratinocyteproliferation
was carried out by the colony forming eﬃciency (CFE)
technique, which was evaluated after 14 days of culturing
with Petri dishes. All the nebulised samples showed at least6 Journal of Biomedicine and Biotechnology
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Figure 5: Comparison between normal skin (NS) and alloplastic
acellular glycerolized dermis (AAGD) viability. There are no viable
cells in the AAGD. The results refer to day 0.
15 colonies, with a regular shape and small dimensions (data
not shown).
Immunohistochemistry and cellular viability were tested
at 7 day intervals (7, 14, and 21) to verify the proliferation,
diﬀerentiation and maturation of the cells on the scaﬀold.
3.3.1. Histology of the AAGD+ Primary Cultured Ker-
atinocytes. A continuous double-layer of keratinocytes was
clearly detected at 7 days. It was observed that the ker-
atinocytes tended to inﬁltrate between the dermal papillae
of the scaﬀold (Figure 6(a)). A pluristratiﬁed layer was
present at 14 days (Figure 6(b)), which was completely
diﬀerentiated at 21 days with a well-represented stratum
corneum (Figure 6(c)).
3.3.2. Histology of the AAGD+ Uncultured Keratinocytes.
There were foci and/or scattered cells at 7 days (Figure 7(a)).
Thecellularmorphologyoftheunculturedkeratinocyteswas
elongated, with abundant cytoplasm, diﬀering from typical
basal cells in healthy skin, which are spherical and have
scarce cytoplasm. A pluristratiﬁed layer invaginating into
the dermis scaﬀold and colonising epidermal appendages
(Figure 7(b))w a sp r e s e n ta t1 4d a y s .T h en e w l yf o r m e d
epithelium was completely diﬀerentiated at 21 days and
showed an evident stratum corneum (Figure 7(c)).
3.3.3. Immunohistochemistry. The newly formed epithelium
was analysed to evaluate the keratinocyte diﬀerentiation and
maturation, compared to that of healthy skin (Figure 8).
The immunohistochemistry results did not diﬀer between
primary and uncultured cells. The cytokeratin AE1/AE3
expressions were analysed by staining biosubstitute and
normal skin (NS) with an antiCytokeratin AE1/AE3 MoAb.
There was a well-evidenced antibody reactivity in the
NS section of all the epithelial layers (Figure 8(a)). The
biosubstitute sections showed a cytoplasmic strong positivity
staining in the monolayer, or cell foci at 7 days. Whilst, at 14
days the typical cytoplasmic positivity extended to the whole
newly formed epithelium, involving also the pluristratiﬁed
areas in the dermal papillae invagination (Figure 8(b)),
which remained unaltered at 21 days.
The NS sections showed a negative antiCytokeratin
16 antibody staining (Figure 8(c)). Conversely, either the
monolayer, or cell foci, stained positively in the biosubstitute
biopsy sections at 7 days. A positivity in the keratinocyte
cytoplasm throughout the suprabasal region with a negative
epithelium basal layer was detected at 14 days (Figure 8(d)).
Therewasanegativebasallayerinthecutaneousappendages,
although the more superﬁcial layers were positive at 21 days.
The antiCytokeratin 14 antibody stained the pluris-
tratiﬁed epithelium layers, showing a uniform positive
membranestaininginNS,commontoalllayers(Figure 9(a))
and cutaneous appendages. Analysing our biosubstitute at
7 days, the keratinocyte cytoplasm and membrane stained
positively for both the monolayer and the cell foci. At 14 and
21 days, there was cytoplasmic positive staining throughout
the whole of the newly formed epithelium and cutaneous
appendages (Figure 9(b)).
The E-cadherin antigen expression stained positively on
theNScellmembraneatalllayers(Figure 9(c)).At7days,the
biosubstitute sections showed positivity in the keratinocyte
cytoplasm, as did the basement membrane of the monolayer.
Staining was observed in all epithelial layers (Figure 9(d)),
also in the cutaneous appendage keratinocytes at 14 and 21
days.
3.3.4. Assessment of the Biosubstitute Viability. The viability
of the newly formed epithelium was assessed by an MTT test
on the biosubstitute. A normal skin sample was used as a
positive control for viability. The biosubstitute was analysed
at 7, 14, and 21 days after cell nebulization. The results
evidenced the presence of viable cells in the biosubstitute
as early as 7 days, with an increase in the positivity, which
paralleled the growth and epidermal layer development over
time (Figure 10). These data conﬁrmed the results obtained
by the immunohistological analysis (Figures 6 and 7).
4. Discussion
Tissue engineering is a multidisciplinary ﬁeld focused on in
vitro reconstruction of mammalian tissues. In order to allow
a three-dimensional organisation of in vitro cultured cells,
biocompatible scaﬀolds are needed.
The choice of alloplastic dermis as a scaﬀold is deter-
minedbythefactthatitretainsalmostallhealthymechanical
skin properties, being compact and elastic, able to take
into the bed wound, providing a barrier against invading
organisms: it is considered, to date, the best skin substitute
available. Moreover it has been demonstrated that allo-
plastic dermis is a good support for the transplant of in
vitro cultured keratinocytes [15, 16]. In addition glycerol-
preserved skin allografts maintain intact tissue morphologyJournal of Biomedicine and Biotechnology 7
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Figure 6: Histomorphological analysis performed on the biosubstitute sections obtained from primary culture keratinocytes at (a) 7 days,
(b) 14 days, (c) 21 days post nebulization. Original magniﬁcation: 10x. AAGD: alloplastic acellular glycerolized dermis; NFE: newly formed
epithelium.
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Figure 7: Histomorphological analysis performed on the biosubstitute sections obtained from uncultured keratinocytes at (a) 7 days, (b) 14
days, (c) 21 days post nebulization. Arrows indicate the foci and/or scattered keratinocytes. Original magniﬁcation: 10x. AAGD: alloplastic
acellular glycerolized dermis; NFE: newly formed epithelium.
and show a strong decrease in tissue antigenicity compared
to cryopreserved ones [11].
We hypothesised that the de-epithelialization of glyc-
erolized skin may be an important phase in skin substitute
preparation, because an adequate preservation of the base-
ment membrane could be fundamental for both adhesion
and cell growth. This prompted us to carry out research as to
the best technique able to allow for a successful cell growth
with a minimum manipulation.
To this aim immunohistochemical analysis was per-
formed on the de-epithelialized alloplastic glycerolized
dermis grafts, obtained by three methods, to verify the
conservation state of the basement membrane. The ﬁrst
technique was based on dispase II enzyme used by Herson
et al. [16]. Immunohistochemistry demonstrated absence of
the basal membrane and, although there was a good initial
keratinocyte take, at two weeks the cells began to detach
from the scaﬀold, indicating poor cell adhesion. The second
technique used trypsin treatment. Histology showed only an
interrupted monolayer of cells. The epithelial removal was
done manually in the third technique, with no addition of
any enzyme. Histology evidenced a good cell proliferation at
7 days, which increased constantly to form multiple layers
within 14 and 21 days. The last was, therefore, considered the
most suitable technique for scaﬀold preparation, conﬁrming
the hypothesis that the basement membrane preservation8 Journal of Biomedicine and Biotechnology
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Figure 8: Immunohistochemical localization of human keratin in NS ((a) and (c)) and biosubstitute sections ((b) and (d)) at 14 days. ((a)
and (b)): The sections were stained with cytokeratin AE1/AE3 Moab and ((c) and (d)) cytokeratin 16 Moab. Original magniﬁcation: 10x. E:
epidermis, De: dermis, AAGD: alloplastic acellular glycerolized dermis, NFE: newly formed epithelium.
promotes the growth and diﬀerentiation of the keratinocytes
seeded on the dermis.
The immunogenicity of the scaﬀold was then evaluated.
Although the morphology and structure of the dermis is
maintained when skin is preserved in glycerol at 85%, it
looses cell viability and is, therefore, scarcely antigenic [11,
17]. Indeed, a low immunogenicity is fundamental for the
preparation of cutaneous substitutes, which must, not only
adhere to the lesion bed, but must also avoid triggering a
rejection. The scaﬀold was analysed for cell immunogenicity
using speciﬁc markers for lymphocytes, macrophages and
dendritic cells. Immunohistochemistry demonstrated that
lymphocytes, macrophages or dendritic cells in the AADG
after ﬁve days of culture were absent. Scaﬀold viability tests
based on MTT salts were negative, indicating that no viable
cells were present in the scaﬀold.
Becauseengineeredtissuesaredesignedforclinicalappli-
cations in humans, a major problem is the possible contami-
nation of cocultures and tissues by xenogenic molecules used
to grow stem cells in vitro. The protocols that are commonly
applied to generate epidermal equivalents in vitro in fact
require the use of irradiated murine ﬁbroblasts (3T3 J2) as a
feederlayerforkeratinocytes.Inthisstudywereportasimple
procedure for growing human keratinocytes, isolated from
adult skin, to generate an epidermal construct on AADG
alone. In fact initially a feeder layer of irradiated murine
3T3 ﬁbroblasts was used, followed by the culture of primary
keratinocytes on the scaﬀold. When the keratinocytes were
cultured directly on alloplastic dermis, no diﬀerence in
keratinocyte proliferation was observed (data not shown). It
was, therefore, decided to avoid the use of murine cells for
the preparation of the biosubstitute.Journal of Biomedicine and Biotechnology 9
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Figure 9: Immunohistochemical localization of human keratin in NS ((a) and (c)) and biosubstitute ((b) and (d)) at 14 days. ((a) and (b)):
The sections were stained with cytokeratin 14 Moab and ((c) and (d)) E-Cadherin Moab. Original magniﬁcation: 10x ((a), (b), and (c)) 20x
(d). E: epidermis, De: dermis, AAGD: alloplastic acellular glycerolized dermis, NFE: newly formed epithelium.
Morphological, immunohistochemical and cytokinetic
features of epithelial colonies grown on the AADG layer
weretypicalofkeratinocytesandwerecomparablewiththose
reported for keratinocytes grown on a feeder layer. In fact
histologyshowedagoodkeratinocytegrowthat7dayswhich
formed a continuous pluristratiﬁed layers within 14/21 days,
and at the same time the viability increased constantly in
direct proportion to the days of culture.
The quality of the newly formed epithelium was evalu-
ated by speciﬁc antibodies directed against cytokeratins and
speciﬁc markers of keratinocyte diﬀerentiation, which have a
varied distribution in cutaneous tissue.
The analysis of cytokeratin 14 shows a distribution
similartohealthyskin,conﬁrmingtheabilityofculturedcells
to form a stratiﬁed epithelium.
Cytokeratin 16 expression is upregulated during pro-
cesses of keratinocyte activation, which occur during wound
healing and is markedly overexpressed in epithelia that dis-
playabnormaldiﬀerentiation,suchasthepsoriaticepidermis
[18–20],while,accordingtoliterature[21],isdownregulated
in NS.
The biosubstitute sections showed a marked cytoplasmic
positivity to CK16 when epithelial cells grow, in the initial
proliferative phase, as a monolayer. On the opposite, when
epithelial cells were pluristratiﬁed, CK16 positivity was
localised only in the most superﬁcial layers, as in epithelial
regenerative processes [22].
The anticytokeratin AE1/AE3 MoAb recognises most
human cytokeratin and identiﬁes epithelial cells in stratiﬁed
and simple layers, and is expressed in the stratum corneum
and the hyperproliferating keratinocytes [23]. All the cor-
neous layer and some keratinocyte foci were positive at the
membrane level in the NS sections, in agreement with liter-
ature. The epithelium of biosubstitute sections was positive10 Journal of Biomedicine and Biotechnology
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Figure 10: The MTT test was used to assess tissue viability in
normal skin (NS) and biosubstitute. A NS sample was used as a
positive control. The viability of skin substitute was analyzed at 7,
14 and 21 days after cell nebulization. A constant increase in the
cell viability was observed over time, parallel to the growth and
epidermal layer development.
at the cytoplasmic level, both in the monostratiﬁed and
pluristratiﬁed areas. The cells of dermal papillae and neo-
colonized appendages were also positive, as was expected, by
regenerating epithelium.
The antiE-cadherin antibody recognizes the transmem-
brane molecules that connect to the actin cytoskeleton via
catenins. The E-cadherin has a signiﬁcant function in the
intercellular adhesion of epithelial cells as it establishes
epithelial polarization, glandular diﬀerentiation and stratiﬁ-
cation. The NS epithelium cell membrane was positive in all
layers, as reported in literature [24]. The antibody staining
was evident both on membrane and cytoplasm in all the
epithelial strata of the biosubstitute sections, demonstrating
that the newly formed epithelium keratinocytes had a
polarization and diﬀerentiation grade comparable to that of
normal epithelial cells. The E-cadherin antigen expression
was negative in the dermal papillae, where the keratinocytes
were still undergoing the process of migration, in agreement
with their diﬀerentiated state.
Takentogetherourimmunohistochemicalresultssuggest
that the newly formed epithelium of the biosubstitute was
comparable to an epidermis in active regeneration as is
observed during the process of wound healing, where the
keratinocytes are in an activated state.
In this paper two diﬀerent keratinocytes suspensions
were used: cultured and uncultured cells. In fact also
uncultured cells were sprayed directly onto the alloplastic
dermis in order to improve the timing of the cells growth.
The biosubstitutes were then monitored to asses any growth
diﬀerences between those of the biosubstitute obtained
with the cultured primary and uncultured cells. The most
signiﬁcant diﬀerences were evident at 7 days where there
was no double-layer in the biosubstitute obtained with
uncultured cells, but only cellular foci that form a multilayer
at 14 days. At 21 days, the newly formed epithelium, in both
cases, was completely diﬀerentiated and showed an evident
stratum corneum. Moreover these data conﬁrmed the results
obtained by the MTT analysis [25].
5. Conclusion
The promising preliminary results obtained in this paper
indicate that the newly formed skin has all the diﬀerentiation
and maturation characteristics of a good cutaneous substi-
tute for clinical application on burn patients and/or other
subjects with serious skin diseases.
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